Salvatore Giovine's most recent trade in Xilio Therapeutics Inc was a trade of 49,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 22, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xilio Therapeutics Inc | Salvatore Giovine | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 49,500 | 49,500 | - | - | Stock Option (right to buy) | |
| Xilio Therapeutics Inc | Salvatore Giovine | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2021 | 28,755 | 28,755 | - | - | Stock Option (right to buy) |